Current report filing

Document And Entity Information

v3.22.2
Document And Entity Information
Jun. 24, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 24, 2022
Entity Registrant Name INHIBIKASE THERAPEUTICS, INC.
Entity Central Index Key 0001750149
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity File Number 001-39676
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 26-3407249
Entity Address, Address Line One 3350 Riverwood Parkway SE
Entity Address, Address Line Two Suite 1900
Entity Address, City or Town Atlanta
Entity Address, State or Province GA
Entity Address, Postal Zip Code 30339
City Area Code 678
Local Phone Number 392-3419
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol IKT
Security Exchange Name NASDAQ